Article Details
Retrieved on: 2024-06-17 22:10:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Disappointing results in Dravet and Lennox-Gastaut syndrome sparked a drop in share value for Ovid Therapeutics, which had partnered on the drug ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here